The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide BPC 157 penis enlargement: What the evidence and real world experience actually show Peptide Therapy in Boise Specialized Treatment for First Responders Blueline Wellness FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News BPC 157 Erectile Dysfunction Study: What the Evidence Actually Shows